Clicky

Estimating the Prevalence of GNE Myopathy Using Population Genetic Databases

Estimating the Prevalence of GNE Myopathy Using Population Genetic Databases
This research estimates the global prevalence of GNE myopathy using allele frequencies from population genetic databases, highlighting potential underdiagnosis and regional differences.
more

Open-label, Blinded, and Double-Blind

This article explains the key differences between open-label, single-blind, and double-blind clinical trial designs, highlighting their impact on research reliability and bias reduction.
more

Safety, tolerability and pharmacokinetics of eteplirsen in young boys aged 6–48 months with Duchenne muscular dystrophy amenable to exon 51 skipping

Safety, tolerability and pharmacokinetics of eteplirsen in young boys aged 6–48 months with Duchenne muscular dystrophy amenable to exon 51 skipping
This open-label trial assesses eteplirsen’s safety in young boys with DMD, confirming its tolerability and predictable pharmacokinetics, but further efficacy studies are needed.
more

Duchenne Muscular Dystrophy Awareness Day - A Personal Journey

Duchenne Muscular Dystrophy Awareness Day - A Personal Journey
This article shares a personal journey in Duchenne muscular dystrophy research, from studying biochemistry to creating a website that simplifies scientific findings for families.
more

Mitochondrial Function in Muscle Stem Cell Fates

Mitochondrial Function in Muscle Stem Cell Fates
This study examines mitochondrial function in muscle stem cells, detailing their role in energy metabolism, differentiation, and regeneration under aging and disease conditions.
more

Revised threshold & Historical threshold

 Revised threshold & Historical threshold
This article explains the differences between revised and historical thresholds in medicine and pharmacology, highlighting their impact on diagnostics, treatment criteria, and drug dosage adjustments.
more

Adrenal Suppression From Vamorolone and Prednisone in Duchenne Muscular Dystrophy: Results From the Phase 2b Clinical Trial

Adrenal Suppression From Vamorolone and Prednisone in Duchenne Muscular Dystrophy: Results From the Phase 2b Clinical Trial
This study examines adrenal suppression in Duchenne muscular dystrophy patients treated with vamorolone and prednisone, emphasizing cortisol thresholds and management strategies.
more

Oligonucleotide Therapies for Facioscapulohumeral Muscular Dystrophy: Current Preclinical Landscape

Oligonucleotide Therapies for Facioscapulohumeral Muscular Dystrophy: Current Preclinical Landscape
This article reviews oligonucleotide-based therapies for facioscapulohumeral muscular dystrophy, highlighting antisense oligonucleotides, RNAi, and CRISPR-based approaches targeting DUX4.
more

A multistage sequencing strategy pinpoints novel candidate alleles for Emery-Dreifuss muscular dystrophy and supports gene misregulation as its pathomechanism

A multistage sequencing strategy pinpoints novel candidate alleles for Emery-Dreifuss muscular dystrophy and supports gene misregulation as its pathomechanism
This study utilizes a multistage sequencing strategy to uncover novel candidate alleles for Emery-Dreifuss muscular dystrophy and supports gene misregulation as a key pathomechanism.
more

MitoNEET preserves muscle insulin sensitivity during ironoverload by regulating mitochondrial iron, reactive oxygenspecies and fission

MitoNEET preserves muscle insulin sensitivity during ironoverload by regulating mitochondrial iron, reactive oxygenspecies and fission
Explore how MitoNEET preserves muscle insulin sensitivity during iron overload by regulating mitochondrial iron, ROS levels, and mitochondrial fission.
more

An update on Becker muscular dystrophy

An update on Becker muscular dystrophy
This article provides an update on Becker muscular dystrophy research, highlighting advances in diagnosis, natural history studies, and emerging treatment approaches.
more

High mobility group box 1 (HMGB1) is a potential disease biomarker in cell and mouse models of Duchenne muscular dystrophy

High mobility group box 1 (HMGB1) is a potential disease biomarker in cell and mouse models of Duchenne muscular dystrophy
Explore the role of HMGB1 as a potential biomarker for Duchenne muscular dystrophy, monitoring disease progression and gene therapy efficacy.
more

Prenatal Exome Sequencing Analysis in Fetuses with Various Ultrasound Findings

Prenatal Exome Sequencing Analysis in Fetuses with Various Ultrasound Findings
This study evaluates the role of prenatal exome sequencing in detecting genetic disorders in fetuses with ultrasound findings, comparing its utility to chromosomal microarray analysis.
more

Transcriptional dysregulation of autophagy in the muscle of a mouse model of Duchenne muscular dystrophy

Transcriptional dysregulation of autophagy in the muscle of a mouse model of Duchenne muscular dystrophy
This study explores autophagy dysregulation in Duchenne muscular dystrophy, highlighting FoxO and TFEB inactivation and resveratrol's role in restoring autophagy.
more

REST/NRSF preserves muscle stem cell identity and survival by repressing alternate cell fates

REST/NRSF preserves muscle stem cell identity and survival by repressing alternate cell fates
This study explores the role of REST/NRSF in preserving muscle stem cell identity by repressing non-muscle genes, ensuring proper regeneration and self-renewal.
more

Recent Posts

Categories

I'd be delighted if you could explore the other sections of my website.

Biochemist Researcher . YouTuber . Medical Laboratory Tech

!I am Ali Nik Akhtar

Personal Website​​​​​​​

If you have any questions or would like to discuss further, please feel free to email me. I would be delighted to get to know you better.

Ready to start a collaboration...​​​​​​​

Contact Me

Nikakhtar422@gmail.com

All rights reserved. This website belongs to Ali Nik Akhtar.